Ελ. Βενιζέλου 144 Νέα Σμύρνη 210 9336319 info@endocrinutri.gr

Treatment of thyroid disorders before conception and in early pregnancy: a systematic review; Vissenberg R, van den Boogaard E, van Wely M, van der Post JA, Fliers E, Bisschop PH, Goddijn M; Human Reproduction Update (Mar 2012)

2020-01-29T13:32:06+00:00

BACKGROUNDThyroid disorders are associated with pregnancy complications. Universal screening is [...]

Treatment of thyroid disorders before conception and in early pregnancy: a systematic review; Vissenberg R, van den Boogaard E, van Wely M, van der Post JA, Fliers E, Bisschop PH, Goddijn M; Human Reproduction Update (Mar 2012)2020-01-29T13:32:06+00:00

Levothyroxine Treatment of Subclinical Hypothyroidism, Fatal and Nonfatal Cardiovascular Events, and Mortality; Razvi S, Weaver JU, Butler TJ, Pearce SH; Archives of Internal Medicine (Apr 2012)

2020-01-29T13:31:26+00:00

BACKGROUND: Subclinical hypothyroidism (SCH) has been associated with ischemic heart [...]

Levothyroxine Treatment of Subclinical Hypothyroidism, Fatal and Nonfatal Cardiovascular Events, and Mortality; Razvi S, Weaver JU, Butler TJ, Pearce SH; Archives of Internal Medicine (Apr 2012)2020-01-29T13:31:26+00:00

Subclinical Hyperthyroidism and the Risk of Coronary Heart Disease and Mortality; Collet TH, Gussekloo J, Bauer DC, den Elzen WP, Cappola AR, Balmer P, Iervasi G, Asvold BO, Sgarbi JA, Völzke H, Gencer B, Maciel RM, Molinaro S, Bremner A, Luben RN, M

2020-01-29T13:30:18+00:00

BACKGROUND: Data from prospective cohort studies regarding the association between [...]

Subclinical Hyperthyroidism and the Risk of Coronary Heart Disease and Mortality; Collet TH, Gussekloo J, Bauer DC, den Elzen WP, Cappola AR, Balmer P, Iervasi G, Asvold BO, Sgarbi JA, Völzke H, Gencer B, Maciel RM, Molinaro S, Bremner A, Luben RN, M2020-01-29T13:30:18+00:00

Role of RANK Ligand and Denosumab, a Targeted RANK Ligand Inhibitor, in Bone Health and Osteoporosis: A Review of Preclinical and Clinical Data; Dempster DW, Lambing CL, Kostenuik PJ, Grauer A; Clinical Therapeutics 34 (3), 521-536 (Mar 2012)

2020-01-29T13:29:39+00:00

BACKGROUND: Postmenopausal osteoporosis results from bone loss and decreased bone [...]

Role of RANK Ligand and Denosumab, a Targeted RANK Ligand Inhibitor, in Bone Health and Osteoporosis: A Review of Preclinical and Clinical Data; Dempster DW, Lambing CL, Kostenuik PJ, Grauer A; Clinical Therapeutics 34 (3), 521-536 (Mar 2012)2020-01-29T13:29:39+00:00

The 10-Year Cost-Effectiveness of Lifestyle Intervention or Metformin for Diabetes Prevention: An intent-to-treat analysis of the DPP/DPPOS; The Diabetes Prevention Program Research Group; Diabetes Care 35 (4), 723-730 (Apr 2012)

2020-01-29T13:29:00+00:00

OBJECTIVE The Diabetes Prevention Program (DPP) and its Outcomes Study [...]

The 10-Year Cost-Effectiveness of Lifestyle Intervention or Metformin for Diabetes Prevention: An intent-to-treat analysis of the DPP/DPPOS; The Diabetes Prevention Program Research Group; Diabetes Care 35 (4), 723-730 (Apr 2012)2020-01-29T13:29:00+00:00

Metformin Use Is Associated with Better Survival of Diabetic Patients with Pancreatic Cancer; Sadeghi N, Abbruzzese JL, Yeung SC, Hassan M, Li D; Clinical Cancer Research (Mar 2012)

2020-01-29T13:25:25+00:00

PURPOSE: Accumulating evidence suggests that metformin has antitumor activity. The [...]

Metformin Use Is Associated with Better Survival of Diabetic Patients with Pancreatic Cancer; Sadeghi N, Abbruzzese JL, Yeung SC, Hassan M, Li D; Clinical Cancer Research (Mar 2012)2020-01-29T13:25:25+00:00
Go to Top